About NetScientific

NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.

NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.

NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.

An entrepreneur-led senior management team with extensive biomedical, healthcare and commercial experience.

  • Sir Richard Sykes FRS

  • François Martelet M.D.

  • Michael Boyce-Jacino PhD

  • David Gough MBA

  • Peter Thoms FCA

  • Vijay Barathan M.D.

Our Portfolio

  • Digital Health
  • Diagnostics
  • Therapeutics

Unique Partnership Model

The partnership with Breakout Labs provides NetScientific and its investors with access to some of the most revolutionary new technologies coming out of Silicon Valley and beyond.


Latest News

RNS Announcements

  • 01-10-2015 – Proposed Placing and Fund Raising to raise GBP 20m >>
  • 01-10-2015 – Half Yearly Report >>
  • 18-09-2015 – Divestment of Shareholding in Frontier BioSciences >>
  • 16-09-2015 – Holding(s) in Company >>
  • 15-09-2015 – Vortex BioSciences granted critical patent >>
  • 09-09-2015 – Steve Curd appointed as CEO of Wanda >>